Bai Bei San Qi

Bai Bei San Qi (Herba Gynurae Divaricatae) is the aerial parts (leaves and tender stems) of Gynura divaricata (L.) DC., a perennial succulent herbaceous plant in the family Asteraceae (daisy family). In the traditional TCM classification system, Bai Bei San Qi is considered bitter in flavor with a cool nature. It enters the Liver and Stomach meridians, giving it a traditional role in formulas that address Heat patterns, Blood Heat, toxicity, traumatic injuries, and bleeding.

Botanical description: Gynura divaricata (L.) DC. is an erect or semi-erect perennial succulent herb growing 30–60 cm tall. The stems are fleshy, green or purplish-green, and sparingly branched. The leaves are alternate, fleshy, broadly ovate to elliptic, 5–15 cm long and 3–10 cm wide, with a crenate or dentate margin. The upper leaf surface is green and glabrous, while the lower surface is characteristically white-pubescent (hence the name "bai bei" or "white back"). The flower heads are borne in terminal corymbs, with orange-red to reddish tubular florets surrounded by green involucral bracts. The plant has a characteristic mild, slightly bitter taste.

Habitat and cultivation: G. divaricata is native to tropical and subtropical regions of Asia and is widely distributed in southern China, including Guangdong, Guangxi, Yunnan, Guizhou, Sichuan, and Hainan provinces. It is also found in India, Nepal, Thailand, Vietnam, Indonesia, the Philippines, and tropical Africa. The plant prefers warm, humid environments and is commonly cultivated in home gardens, farms, and roadsides. In southern China, particularly Guangdong and Guangxi, it is widely grown as a vegetable and medicinal plant. The aerial parts are harvested throughout the year, with fresh material preferred for culinary use and dried material for medicinal purposes.

Quality markers: High-quality Bai Bei San Qi should have intact, fleshy leaves with a clearly white-pubescent lower surface. The leaves should be green on the upper surface without significant yellowing or browning. Premium-grade material has a mild, characteristic aroma and a slightly bitter taste. Material should be free of mold, insect damage, or excessive stem material. Quality control should include screening for pyrrolizidine alkaloid content, as this is the primary safety concern for this herb.

In the traditional Chinese medicine theoretical framework, Bai Bei San Qi is understood in terms of its effects on specific patterns of disharmony (zheng). Because Bai Bei San Qi enters the Liver and Stomach meridians and has a bitter and cool quality, it is traditionally indicated for patterns involving Heat, Blood Heat, toxicity, and traumatic injury.

Clearing heat and cooling blood: Bai Bei San Qi is considered a folk heat-clearing and blood-cooling herb in TCM. In TCM theory, Heat in the Blood level may manifest as fever, epistaxis, hematemesis, hematuria, subcutaneous purpura, and skin eruptions. Bai Bei San Qi's bitter and cool properties are believed to clear Heat from the Blood level and reduce bleeding. It enters the Liver meridian, which is the organ system responsible for storing Blood in TCM theory, making it particularly suitable for Blood Heat patterns. It has been traditionally used for various bleeding conditions and febrile diseases in folk practice. This traditional use is based on TCM pattern differentiation and should not be equated to modern hemostatic or antipyretic treatments.

Resolving toxicity: Bai Bei San Qi is traditionally used to resolve toxicity, particularly in the context of skin conditions, infections, and inflammatory disorders. In folk practice, it has been used for carbuncles, boils, erysipelas, and other suppurative skin conditions. Its bitter and cool properties are believed to counteract Heat-toxin. The fresh herb may be applied as a poultice to affected areas, while the dried herb is decocted for internal use. These applications are based on traditional TCM theory and should not be equated to specific antimicrobial therapies.

Promoting circulation and stopping bleeding: Bai Bei San Qi has a dual traditional action of promoting blood circulation and stopping bleeding. In TCM theory, this combination is valued for conditions where Blood stasis coexists with bleeding — a pattern that may occur in traumatic injuries, menstrual disorders with clots, and certain vascular conditions. For traumatic injuries, the fresh herb is traditionally pounded into a paste and applied to bruises, contusions, and sprains to reduce swelling, relieve pain, and promote tissue healing. For bleeding conditions, it is traditionally taken internally as a decoction. This dual action is reflected in the "San Qi" portion of its name, which refers to the hemostatic and circulatory properties associated with San Qi (Panax notoginseng).

Rheumatic pain: In folk TCM practice, Bai Bei San Qi has been used for rheumatic pain and joint discomfort. Its heat-clearing and circulation-promoting properties are believed to address the Damp-Heat and Blood stasis components of rheumatic conditions. It may be used internally as a decoction or applied externally as a compress to affected joints. This traditional use is based on TCM pattern differentiation and does not represent confirmed treatment for rheumatic diseases.

Dietary and folk use: In southern China, particularly Guangdong and Guangxi provinces, Bai Bei San Qi is widely consumed as a vegetable. It is commonly used in soups, stir-fries, and herbal teas. As a food, it is valued for its cooling properties in the context of the Cantonese food-therapy tradition, where foods are selected based on their energetic properties to maintain health balance. However, the presence of hepatotoxic pyrrolizidine alkaloids raises important safety questions about regular dietary consumption (see Safety section below).

Bai Bei San Qi contains a range of bioactive compounds. The most notable include beneficial flavonoids and sesquiterpenes, as well as the concerning pyrrolizidine alkaloids (PAs). The following overview summarizes the major chemical constituents and what is currently known about them from published research.

Flavonoids (rutin, quercetin): Rutin (quercetin-3-O-rutinoside) and quercetin are the major flavonoid constituents identified in Bai Bei San Qi. Rutin is a flavonoid glycoside widely distributed in many plants and has been extensively studied for its antioxidant, anti-inflammatory, and vascular-protective properties. It has been investigated for its potential to strengthen capillary walls, reduce vascular permeability, and protect against oxidative damage. Quercetin, the aglycone of rutin, is one of the most well-studied dietary flavonoids and has demonstrated anti-inflammatory, antioxidant, antiallergic, and potential cardioprotective activities in pre-clinical research. Both compounds are considered beneficial constituents of Bai Bei San Qi, though human clinical data for this specific herb are limited.

Pyrrolizidine alkaloids (PAs) — Safety Concern: Pyrrolizidine alkaloids are a group of naturally occurring plant toxins found in Gynura divaricata and many other Asteraceae species. These compounds are of major toxicological concern because certain 1,2-unsaturated PAs are hepatotoxic, genotoxic, and potentially carcinogenic. PAs are metabolized in the liver by CYP3A4 and other cytochrome P450 enzymes into reactive dehydro-pyrrolizidine (pyrrolic) intermediates that bind covalently to cellular proteins, DNA, and glutathione, causing hepatocyte necrosis, DNA cross-linking, and sinusoidal endothelial cell damage. Chronic exposure can lead to hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), characterized by fibrosis and occlusion of hepatic venules. The specific PA profile and total PA content in G. divaricata vary depending on growing conditions, plant part, and harvest time, but the hepatotoxic risk is well-established. This is the most critical safety consideration for this herb.

Sesquiterpenes: Bai Bei San Qi contains sesquiterpene compounds that have been less extensively studied than its flavonoid and PA constituents. Sesquiterpenes from Gynura species have shown anti-inflammatory and antioxidant activities in some pre-clinical studies. Their specific contribution to the overall pharmacological or toxicological profile of Bai Bei San Qi requires further investigation.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans. The hepatotoxicity of pyrrolizidine alkaloids is supported by both pre-clinical and clinical evidence.

Bai Bei San Qi is primarily used as a folk medicine herb in TCM practice and is less commonly found in standardized classical formula literature. It is more typically used as a single herb or in simple folk combinations. Below are representative traditional applications.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anti-inflammatory and antioxidant effects: The flavonoid constituents of Gynura divaricata, particularly rutin and quercetin, have been studied for their anti-inflammatory and antioxidant activities. Rutin has demonstrated the ability to scavenge free radicals, inhibit lipid peroxidation, and reduce pro-inflammatory cytokine production in pre-clinical models. Quercetin has been shown to modulate NF-kappaB and MAPK signaling pathways and to inhibit the production of TNF-alpha, IL-6, and COX-2 in LPS-stimulated macrophages. Extracts of G. divaricata have shown antioxidant activity in DPPH and ABTS radical scavenging assays. These pre-clinical findings are promising but should be interpreted alongside the hepatotoxicity risk from PAs present in the same plant.

Antidiabetic potential: Some pre-clinical studies have investigated Gynura divaricata for potential antidiabetic effects. Animal studies have reported that extracts of the herb may reduce blood glucose levels, improve insulin sensitivity, and protect pancreatic beta cells in streptozotocin-induced diabetic rat models. These effects have been attributed to the flavonoid and polysaccharide constituents. However, these findings are derived from animal models only and do not constitute evidence for clinical efficacy in diabetes. The hepatotoxic risk from PAs is an important consideration that limits any potential therapeutic application of this herb for metabolic conditions.

Pyrrolizidine alkaloid hepatotoxicity — Established Risk: Unlike the beneficial compounds, the hepatotoxicity of pyrrolizidine alkaloids is supported by extensive clinical and pre-clinical evidence from multiple plant species. PAs from Gynura species and other Asteraceae plants have been documented to cause hepatic veno-occlusive disease (VOD/SOS) in humans. The German Federal Institute for Risk Assessment (BfR), the European Food Safety Authority (EFSA), and other regulatory bodies have issued scientific opinions on PA-containing plants, recommending that exposure to 1,2-unsaturated PAs should be minimized to as low as reasonably achievable. Chronic dietary exposure to PAs has been linked to liver fibrosis, cirrhosis, and VOD. Boiling, steaming, and other conventional cooking methods do NOT reliably degrade PAs to safe levels. This is a well-established safety concern that significantly impacts the risk-benefit assessment for Bai Bei San Qi.

What the research does NOT show: Despite some promising pre-clinical signals for the flavonoid constituents, the research on Bai Bei San Qi does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Bai Bei San Qi can treat, cure, or prevent diabetes, inflammatory disorders, bleeding conditions, or any other medical condition. The presence of hepatotoxic PAs in this plant represents a significant safety concern that outweighs the limited pre-clinical evidence for beneficial effects. This page does not endorse Bai Bei San Qi as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research), except for the hepatotoxicity of pyrrolizidine alkaloids, which is supported by clinical evidence. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile — Elevated concern: Bai Bei San Qi carries a higher-than-average safety concern among TCM herbs due to the confirmed presence of hepatotoxic pyrrolizidine alkaloids (PAs). While the herb has a long history of folk use as both food and medicine in southern China, the modern recognition of PA hepatotoxicity demands a reassessment of its safety profile. The information below reflects the current state of scientific understanding.

Hepatotoxic pyrrolizidine alkaloids (PAs): This is the most important safety consideration for Bai Bei San Qi. PAs from Gynura species are known hepatotoxins that can cause hepatic veno-occlusive disease (VOD/SOS), a condition characterized by fibrosis and occlusion of the hepatic venules leading to liver enlargement, ascites, jaundice, and potentially fatal liver failure. The toxicity is cumulative with chronic exposure, meaning that regular consumption over time — even at low doses — may lead to progressive liver damage. The risk is present regardless of whether the herb is consumed as medicine, food, or tea. Conventional cooking and processing methods do NOT reliably destroy PAs. Individuals with pre-existing liver disease are at particularly elevated risk.

Populations that should avoid Bai Bei San Qi: The following groups should avoid Bai Bei San Qi entirely: individuals with known liver disease (including hepatitis, cirrhosis, fatty liver, or elevated liver enzymes); individuals with a history of hepatic VOD/SOS; pregnant women (PAs can cross the placenta and may harm the fetus); breastfeeding women (PAs can pass into breast milk); children (who may be more susceptible to PA toxicity); and individuals taking hepatotoxic medications (risk of additive liver injury). Elderly individuals and those with compromised liver function should also exercise extreme caution.

Spleen-Stomach deficiency-cold: In traditional TCM theory, Bai Bei San Qi is bitter and cool in nature. Individuals with Spleen-Stomach deficiency-cold — characterized by poor appetite, abdominal distension, loose stools, and a pale tongue with white coating — should use this herb with caution, as its cool nature may worsen digestive weakness.

Drug interactions: PAs are metabolized by hepatic CYP3A4. Concurrent use of CYP3A4 inhibitors (e.g., certain antifungals, macrolide antibiotics, grapefruit juice) could theoretically increase PA bioavailability and hepatotoxicity risk. Concurrent use of CYP3A4 inducers could theoretically alter PA metabolism. The flavonoid constituents may also affect CYP enzyme activity. Clinical interaction data for Bai Bei San Qi specifically are very limited. Consult a qualified healthcare professional before combining Bai Bei San Qi with any prescription medications.

Liver function monitoring: Anyone considering the use of Bai Bei San Qi — even under professional guidance — should have baseline liver function tests and periodic monitoring. Signs of liver toxicity including unexplained fatigue, abdominal swelling, jaundice, dark urine, or pale stools should prompt immediate discontinuation and medical evaluation.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Bai Bei San Qi or any other herbal product for the treatment of any medical condition. The presence of hepatotoxic pyrrolizidine alkaloids in this herb represents a significant safety concern that should be carefully weighed against any potential benefits. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.